Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01752231 · ClinicalTrials.gov registry record
Optimization of Novel DCE-MRI Imaging Sequences for Cancer Therapy Monitoring
A clinical trial, sponsored by City of Hope Medical Center.
- Terminated
- Registry status
- 1
- Enrollment target
NCT01752231: Clinical Trial study, sponsored by City of Hope Medical Center.
NCT01752231 is a clinical trial that was terminated before completion, run by City of Hope Medical Center. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01752231 was terminated before completion, sponsored by City of Hope Medical Center.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
This pilot clinical trial studies dynamic contrast enhanced (DCE)-magnetic resonance imaging (MRI) in diagnosing cancer. New diagnostic procedures, such as DCE-MRI may help find and diagnose cancer
Primary Outcome
Analysis of DCE-MRI data will be by semi-quantitative metrics such as the area under the curve (AUC), the slopes of contrast agent uptake and washout curves as well as peak contrast agent uptake. Alternatively quantitative metrics based upon pharmacokinetic modeling will be derived. The model is the 2-compartment Kety model from which volume transfer constants between compartments and volume of the tissue compartments can be calculated.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-07-23 |
| Est. Completion | 2017-08-29 |
Why NCT01752231 stopped before completion
NCT01752231 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01752231 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01752231 about?
NCT01752231 is a clinical study titled "Optimization of Novel DCE-MRI Imaging Sequences for Cancer Therapy Monitoring". This pilot clinical trial studies dynamic contrast enhanced (DCE)-magnetic resonance imaging (MRI) in diagnosing cancer. New diagnostic procedures, such as DCE-MRI may help find and diagnose cancer
What is the current status of trial NCT01752231?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2013-07-23. Estimated completion is 2017-08-29.
Who is sponsoring clinical trial NCT01752231?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI